Literature DB >> 4261090

Contribution of quantitative assay technics to the understanding of the clinical pharmacology of digitalis.

T W Smith.   

Abstract

Mesh：

Substances：

Year:  1972        PMID： 4261090     DOI： 10.1161/01.cir.46.1.188

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  10 in total

1.  Therapeutic and toxic lanatoside C serum concentrations in hospital patients.

Authors:  J Karjalainen; K Ojala
Journal:  Klin Wochenschr       Date:  1975-07-15

Review 2.  Clinical pharmacology and therapeutics use of digitalis glycosides.

Authors:  J E Doherty; J J Kane
Journal:  Drugs       Date:  1973       Impact factor: 9.546

3.  [Plasma levels, elimination and cumulation of proscillaridin in renal failure (author's transl)].

Authors:  G G Belz; W J Brech
Journal:  Klin Wochenschr       Date:  1974-07-01

4.  The influence of metabolites of digoxin and digitoxin on the 86Rb-uptake assay.

Authors:  J M Kaufman; F M Belpaire
Journal:  Eur J Clin Pharmacol       Date:  1973-06       Impact factor: 2.953

5.  Therapeutic non-equivalence of digoxin tablets in the United Kingdom: correlation with tablet dissolution rate.

Authors:  T R Shaw; K Raymond; M R Howard; J Hamer
Journal:  Br Med J       Date:  1973-12-29

6.  A standard approach to compiling clinical pharmacokinetic data.

Authors:  L B Sheiner; L Z Benet; L A Pagliaro
Journal:  J Pharmacokinet Biopharm       Date:  1981-02

7.  Skeletal muscle digoxin concentration during digitalization and during withdrawal of digoxin treatment.

Authors:  T Jogestrand; F Ericsson; K Sundqvist
Journal:  Eur J Clin Pharmacol       Date:  1981-01       Impact factor: 2.953

8.  [A simplified radioimmunoassay for digoxin determination using a 125-j-labelled, solid-phase kit (author's transl)].

Authors:  W Doering; E Blümel
Journal:  Klin Wochenschr       Date:  1978-05-15

9.  Removing substances from blood by affinity chromatography. I. Removing bilirubin and other albumin-bound substances from plasma and blood with albumin-conjugated agarose beads.

Authors:  P H Plotz; P D Berk; B F Scharschmidt; J K Gordon; J Vergalla
Journal:  J Clin Invest       Date:  1974-03       Impact factor: 14.808

10.  Synergistic effects of ion transporter and MAP kinase pathway inhibitors in melanoma.

Authors:  Ugur Eskiocak; Vijayashree Ramesh; Jennifer G Gill; Zhiyu Zhao; Stacy W Yuan; Meng Wang; Travis Vandergriff; Mark Shackleton; Elsa Quintana; Timothy M Johnson; Ralph J DeBerardinis; Sean J Morrison
Journal:  Nat Commun       Date:  2016-08-22       Impact factor: 14.919
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.